Marvin Mandel, Governor                        1097

3.    Not more than 300 milligrams of dihydrocodeinone per 100
milliliters or not more than 15 milligrams per dosage unit, with a
fourfold or greater quantity of an isoquinoline alkaloid of opium.

4.    Not more than 300 milligrams of dihydrocodeinone per 100
milliliters or not more than 15 milligrams per dosage unit, with one
or more active, non-narcotic ingredients in recognized therapeutic
amounts.

5.    Not more than 1.80 grams of dihydrocodeine per 100 milli-
liters or not more than 90 milligrams per dosage unit, with one or
more active, non-narcotic ingredients in recognized therapeutic
amounts.

6.    Not more than 300 milligrams of ethylmorphine per 100 milli-
liters or not more than 15 milligrams per dosage unit, with one or
more active, non-narcotic ingredients in recognized therapeutic
amounts.

7.    Not more than 500 milligrams of opium per 100 milliliters or
per 100 grams, or not more than 25 milligrams per dosage unit, with
one or more active, non-narcotic ingredients in recognized thera-
peutic amounts. Not more than 100 milligrams of opium per 100
milliliters or per 100 grams, or not more than 5 milligrams per
dosage unit.

8.    Not more than 50 milligrams of morphine per 100 milliliters
or per 100 grams with one or more active, non-narcotic ingredients
in recognized therapeutic amounts.

e. The Department may by regulation except any compound mix-
ture, or preparation containing any stimulant or depressant sub-
stance listed in paragraphs (a) and (b) of this schedule above from
the application of all or any part of this subheading if the compound,
mixture, or preparation contains one or more active medicinal in-
gredients not having a stimulant or depressant effect on the central
nervous system; provided, that such admixtures shall be included
therein in such combinations, quantity, proportion, or concentration
as to vitiate the potential for abuse of the substances which do have
a stimulant or depressant effect on the central nervous system.

(d) Schedule IV—In determining that a substance comes within
this schedule, the Department shall find that:

1.    the substance has a low potential for abuse relative to the sub-
stances listed in Schedule HI; and

2.    the substance has currently accepted medical use in treatment
in the United States; and

3.    abuse of the substance may lead to limited physical dependence
or psychological dependence relative to the substances in Schedule III.
The following are controlled substances and are included in this
Schedule:

a. Any material, compound, mixture, or preparation which con-
tains any quantity of the following substances having a potential for
abuse associated with a depressant effect on the central nervous
system:

(1)  Barbital;

(2)  Chloral betaine;